PATH trades against a final fair-value range of $8.05-$13.97, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $8.05, high $14.0, with mid-point at $11.0.
Trades close to fair value, so the margin of safety is limited either way.
Fair value
$11
Margin of safety
+1.7%
Confidence
84/100
Moat
6.5/10
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
$10.79Price
Low $8.05
Mid $10.98
High $13.97
PATH trades against a final fair-value range of $8.05-$13.97, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
High switching costs embedded deep
High switching costs embedded deep within enterprise legacy workflows.
Incumbent scale and broad integrations
Incumbent scale and broad integrations in traditional RPA markets.
Cycle upside
Enterprise AI adoption drives massive structural process orchestration needs across sectors.
PATH (PATH)'s margin set covers gross margin, operating margin, net margin, and free-cash-flow margin. The five-year trajectory is plotted so the reader can separate cyclical noise from secular trend.
Margin expansion or compression is read against the revenue base: if operating margin expands while revenue grows, that is operating leverage. If gross margin compresses, the cause (mix shift, input costs, pricing) is annotated in the numbers analysis.
Peer-relative margin context lives on the parent peers tab, which sets PATH's gross, operating, and net margins against four to five named peers from the same archetype and sector.
FCF margin is reported alongside operating margin so the reader can spot cases where capex intensity changes the cash-conversion read even when reported profitability is steady.
FAQ
PATH — frequently asked questions
Based on our latest analysis, PATH trades close to fair value. The current price is $10.8 versus a composite fair-value midpoint of $11.0 (range $8.05–$14.0), which implies roughly 1.8% upside to the midpoint.
Our composite fair-value range for PATH is $8.05–$14.0, with a midpoint of $11.0. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for PATH's archetype.
Our current rating for PATH is Hold with a confidence score of 84/100. PATH is rated Hold at $10.79 versus the reconciled fair value midpoint of $10.98, implying +1.76% upside/downside. Confidence is separately disclosed at 84/100. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for PATH are: AI Generative Disruption; Structural Margin Stagnation; Uncontrolled SBC Escalation. The single biggest risk is AI Generative Disruption: Generative AI agents bypass traditional RPA workflows entirely, collapsing gross margins and pipeline growth.
Our current rating for PATH is Hold, issued with a confidence score of 84/100 and a moat score of 6.5/10. The rating reflects the composite fair-value range ($8.05–$14.0) versus the current price of $10.8.
PATH is classified as a mature compounder stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for PATH.
